MYRIAD GENETICS INC (MYGN) Insider Trading -- Recent Executive & Director Transactions

21 insiders reported 133 Form 4 transactions for MYRIAD GENETICS INC (MYGN) over the past 18 months (most recent 2026-08-17). Recent activity: Wheeler Benjamin Richard (Chief Financial Officer) Sell 8,761 shares, Raha Samraat S. (President and CEO) Buy 3,542 shares, Donnelly Brian J (Chief Commerical Officer) Buy 5,000 shares, Kumar Rashmi (Director) Sell 15,000 shares, Skovronsky Daniel (Director) Buy 59,701 shares. Source: SEC Form 4.

DateInsiderTitleTypeSharesValue
2026-08-17Wheeler Benjamin RichardChief Financial OfficerSell8,761$26,546
2026-06-12Raha Samraat S.President and CEOBuy3,542$13,941
2026-06-12Donnelly Brian JChief Commerical OfficerBuy5,000$19,680
2026-06-09Kumar RashmiDirectorSell15,000$66,843
2026-06-05Skovronsky DanielDirectorBuy59,701$0
2026-06-05Dreismann HeinrichDirectorBuy59,701$0
2026-06-05Phanstiel S. LouiseDirectorBuy59,701$0
2026-06-05Reitan Colleen FDirectorBuy59,701$0
2026-06-05Bisaro PaulDirectorBuy59,701$0
2026-06-05Newcomer Lee NisleyDirectorBuy59,701$0
2026-06-05Kumar RashmiDirectorBuy59,701$0
2026-06-05Davis Mark StevenDirectorBuy59,701$0
2026-06-02Jampa RajChief Technology OfficerBuy251,889$0
2026-05-14Bisaro PaulDirectorBuy7,500$27,638
2026-05-04Donnelly Brian JChief Commerical OfficerSell55,975$268,680
2026-04-15Verratti MarkChief Operating OfficerSell1,069$5,249
2026-04-15Muzzey DaleChief Scientific OfficerSell946$4,645
2026-03-23Verratti MarkChief Operating OfficerSell2,055$9,412
2026-03-23Muzzey DaleChief Scientific OfficerSell2,019$9,247
2026-03-23Wheeler Benjamin RichardChief Financial OfficerSell549$2,514
2026-03-16Verratti MarkChief Operating OfficerSell5,418$25,248
2026-03-16Fox Jennifer LynneChief Legal OfficerBuy195,876$0
2026-03-16Fox Jennifer LynneChief Legal OfficerSell5,995$27,937
2026-03-16Verratti MarkChief Operating OfficerBuy247,423$0
2026-03-16Verratti MarkChief Operating OfficerSell9,164$42,704

Source: SEC Form 4 filings · as of 2026-08-17